Proto Financial Statements From 2010 to 2025

PSCR Stock  USD 0.0001  0.00  0.00%   
Proto Script's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Proto Script's valuation are provided below:
Proto Script Pharmaceutical does not presently have any trending fundamental ratios for analysis.
Check Proto Script financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Proto Script's main balance sheet or income statement drivers, such as , as well as many indicators such as . Proto financial statements analysis is a perfect complement when working with Proto Script Valuation or Volatility modules.
  
This module can also supplement various Proto Script Technical models . Check out the analysis of Proto Script Correlation against competitors.

Proto Script Pharmaceutical Company Return On Asset Analysis

Proto Script's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Proto Script Return On Asset

    
  -2.41  
Most of Proto Script's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Proto Script Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Proto Script Pharmaceutical has a Return On Asset of -2.4096. This is 372.47% higher than that of the Industrials sector and significantly lower than that of the Specialty Business Services industry. The return on asset for all United States stocks is notably higher than that of the company.

Proto Script Pharmac Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Proto Script's current stock value. Our valuation model uses many indicators to compare Proto Script value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Proto Script competition to find correlations between indicators driving Proto Script's intrinsic value. More Info.
Proto Script Pharmaceutical is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Proto Script's earnings, one of the primary drivers of an investment's value.

About Proto Script Financial Statements

Proto Script shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Proto Script investors may analyze each financial statement separately, they are all interrelated. The changes in Proto Script's assets and liabilities, for example, are also reflected in the revenues and expenses on on Proto Script's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California. Proto Script operates under Specialty Business Services classification in the United States and is traded on OTC Exchange.

Pair Trading with Proto Script

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Proto Script position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Proto Script will appreciate offsetting losses from the drop in the long position's value.

Moving against Proto Pink Sheet

  0.86RBA RB GlobalPairCorr
  0.64CTAS CintasPairCorr
  0.57GPN Global PaymentsPairCorr
  0.46TLPFF Teleperformance SEPairCorr
  0.43RKLIF Rentokil Initial plcPairCorr
The ability to find closely correlated positions to Proto Script could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Proto Script when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Proto Script - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Proto Script Pharmaceutical to buy it.
The correlation of Proto Script is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Proto Script moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Proto Script Pharmac moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Proto Script can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Proto Pink Sheet Analysis

When running Proto Script's price analysis, check to measure Proto Script's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proto Script is operating at the current time. Most of Proto Script's value examination focuses on studying past and present price action to predict the probability of Proto Script's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proto Script's price. Additionally, you may evaluate how the addition of Proto Script to your portfolios can decrease your overall portfolio volatility.